Samira Behi, | |
6525 University Ave Ne, Fridley, MN 55432-4331 | |
(763) 586-0730 | |
Not Available |
Full Name | Samira Behi |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 6525 University Ave Ne, Fridley, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063280717 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 126338 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Samira Behi, 6525 University Ave Ne, Fridley, MN 55432-4331 Ph: (763) 586-0730 | Samira Behi, 6525 University Ave Ne, Fridley, MN 55432-4331 Ph: (763) 586-0730 |
News Archive
The combination of rising Medicare premiums and no annual cost-of-living adjustment (COLA) would reduce Social Security payments for about 23 million of the nation's seniors in 2011, according to The Senior Citizens League. This figure represents two-thirds of the 37 million seniors who receive Social Security benefits.
Particle Sciences, Inc (PSI), has completed the manufacturing of clinical supplies for the first in human studies of KX2-361 (KX02), Kinex Pharmaceuticals' small molecule Src/pre-tublin inhibitor.
The health law's Medicaid expansion - and its cost to state bottom lines - is making news among lawmakers, candidates and advocates in Kansas, Washington state, South Carolina and Arizona.
Doing a little detective work can go a long way in finding skin cancer, the most common form of cancer diagnosed in the United States, at its earliest, most treatable stage. However, a new survey found that many people do not know how to spot skin cancer and are unaware of their risk of developing the disease.
CASI Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today that China's Food and Drug Administration has approved the Company's application to conduct a Phase II clinical trial in triple-negative breast cancer (TNBC) patients in China for its proprietary drug candidate, ENMD-2076.
› Verified 2 days ago
Daniel Husak, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 550 Osborne Rd Ne, Fridley, MN 55432 Phone: 763-236-4123 | |
William S Johnson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 755 53rd Ave Ne, Fridley, MN 55421 Phone: 763-571-9766 Fax: 763-852-0086 | |
Dr. Sheiren Farag-el-massah, PHARM.D., PH.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6525 University Ave Ne, Walgreens Pharmacy, Fridley, MN 55432 Phone: 763-586-0730 | |
Ann M Toscano, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5255 E River Rd, Suite 204, Fridley, MN 55421 Phone: 763-571-2220 | |
Dr. Camanh Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7411 University Ave Ne, Fridley, MN 55432 Phone: 512-799-6561 | |
Dr. Jennifer Sorman Gednalske, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 550 Osborne Rd Ne, Mail Code 52570, Fridley, MN 55432 Phone: 763-236-4123 |